JANICE HUR
Yale doctors weigh in on the first FDA-approved schizophrenia drug in nearly 30 years
For the first time in nearly 30 years, the U.S. Food and Drug Administration has approved a new drug treating schizophrenia, offering hope for patients who have struggled with the limitations of previous medications.
October 7, 2024